TABLE 4.
Multivariable competing risk regression analysis of clinical factors and osteoradionecrosis
Induction chemotherapy | No induction chemotherapy | |||
---|---|---|---|---|
Variable | HR (95% CI) | P | HR (95% CI) | P |
Hypomagnesemia during treatment course | ||||
No | Reference | |||
Yes | 2.72 (1.06–6.97) | .037 | 0.93 (0.54–1.62) | .81 |
Radiation dose | 1.07 (0.95–1.20) | .260 | 0.98 (0.91–1.06) | .66 |
Smoking | ||||
No | Reference | |||
Yes | 2.05 (0.98–4.29) | .056 | 1.17 (0.67–2.05) | .58 |
Tumor (T classification)a | ||||
Tx, T0 or T1 | Reference | |||
T2 | 1.74 (0.66–4.59) | .260 | ||
T3 | 2.38 (0.85–6.68) | .099 | ||
T4 | 2.78 (1.01–7.64) | .047 |
Note: The values marked in bold italics indicate statistical significance (P < .05).
Abbreviations: CI, confidence interval; HR, hazard ratio.
In no induction group only.